Camelia Iancu-Rubin

Camelia Iancu-Rubin, PhD

  • ASSOCIATE PROFESSOR | Pathology, Molecular and Cell Based Medicine
  • ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology

Research Topics:

Blood, Cancer, Cell Biology, Differentiation, Fibrosis, Hematopoiesis, Leukemia, Molecular Biology, Translational Research

Dr. Iancu-Rubin completed her Bachelor and Master Degrees at the University of Bucharest in Romania in 1989 and 1992, respectively. She pursued a career in clinical laboratory medicine and teaching until 1997 when she was awarded a Fulbright Fellowship in biomedical sciences. As Fulbright Scholar she completed her graduate studies at the Graduate School of Biomedical Sciences at Mount Sinai Medical Center in New York. Dr. Iancu-Rubin received her Ph.D. in Life Sciences in 2000 and did her post-doctoral training in hematology. Currently, she is faculty member of the NCI-designated Tisch Cancer Institute and of the Department of Medicine at Icahn School of Medicine at Mount Sinai  and the Director of Hematological Malignancies Tissue Bank. Dr. Iancu-Rubin has been investigator on NIH-funded, foundation and institutional projects as well as on industry-sponsored preclinical and clinical studies. She is conducting research independently and within the MPN and NYSTEM Research Consortiums. Her research focuses on normal and malignant hematopoiesis and megakaryopoiesis with emphasis on pre-clinical and clinical evaluation of drug-based and cellular therapies for patients with hematological malignancies. Dr. Iancu-Rubin’s research has been recognized in highly ranked peer-reviewed publications and her expertise has been sought by multiple collaborators.


MS, University of Medicine and Pharmacy

PhD, University of Bucharest

Mount Sinai School of Medicine